Case of congenital Langerhans cells histiocytosis in an infant
https://doi.org/10.17650/1818-8346-2011-6-2-19-22
Abstract
In this article a rare case of monosystem form of congenital Langerhans cells histiocytosis (LCH) in 3 weeks of age girl was described. Local lesion of oral mucosa of the infant with LCH was first described. Morphological, immunological and clinical features of this rare disease have been characterized. Authors concluded that timely diagnostics is very important to risk-adapted therapy at children with LCH.
About the Authors
T. T. ValievRussian Federation
L. A. Makhonova
Russian Federation
A. M. Kovrigina
Russian Federation
E. N. Sholokhova
Russian Federation
N. N. Tupitsyn
Russian Federation
I. N. Serebryakova
Russian Federation
G. L. Mentkevich
Russian Federation
References
1. Махонова Л.А., Дурнов Л.А. Гистиоцитарные заболевания у детей. М.: МИА, 2004. С. 93.
2. Новичкова Г.А., Минков М., Масчан М.А. и др. Гистиоцитозы. В кн.: Клиническая онкогематология. Под ред. М.А. Волковой. М.: Медицина, 2007. С. 891–911.
3. Swerdlow S.H., Campo E., Harris N.L. et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th Ed. International Agency for Research on Cancer. Lyon, 2008. P. 439.
4. Волкова Е.Н., Бронин Г.О., Высоцкая Т.А. и др. Результаты ретроспективного моно- центрового исследования гистиоцитоза из клеток Лангерганса у детей. Педиатрия 2009;87(3):33–40.
5. Buchman L., Emani A., Wei J.L. Primary head and neck Langerhans cell histiocytosis in children. Otolaryngol Head Neck Surg;135:312–7.
6. Лукина Е.А. Гистиоцитоз из клеток Лангерганса. В рук. по гематологии под ред. акад. А.И. Воробьева. М.: Ньюдиамед, 2003. С. 36–39.
7. Krstovski N., Janic D., Docmanovic L. et al. Clinical characteristics and survival of children with Langerhans cell histiocytosis. Spr Arh Celok Lek 2008;136(9–10):514–8.
8. Mosterd K., van Marion A., van Steensel M.A. Neonatal Langerhans cell histiocytosis: a rare and potentially life-threatening disease. Int J Dermatol 2008;47(1):10–2.
9. Солопова Г.Г., Байдильдина Д.Д., Жарикова Л.И. и др. Применение 2-хлор- дезоксиаденозина в терапии гистиоцитоза из клеток Лангерганса у детей. Онкогематология 2010;3:8–15.
10. Imamura T., Sato T., Shiota Y. et al. Outcome of pediatric patients with Langerhans cell histiocytosis treated with 2 chlorodeoxyadenosine: a nationwide survey in Japan. Int J Hematol 2010 May;91(4):646–51.
11. Weitzman S., Braier J., Donadieu J. et al. 2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). Results of the LCH-S-98 protocol of the Histiocyte Society. Pediatr Blood Cancer 2009 Dec 15;53(7):1271–6.
12. Stein S.L., Paller A.S., Haut P.R. et al. Langerhans Cell Histiocytosis Presenting in the Neonatal Period. Arch Pediatr Adolesc Med;155:778–83.
13. Connolly L.P., Treves S.T. Assessing the limping child with skeletal scintigraphy. J Nucl Med 1998 Jun;39(6):1056–61.
14. Freeman S.J., Sonoda L.I., Seshadri N. et al. What is the significance of solitary bony abnormalities on bone scintigrams of children with malignancy? Pediatr Hematol Oncol 2010 Aug;27(5):380–6.
15. Allen C.E., McClain K.L. Langerhans cell histiocytosis: a review of past, current and future therapies. Drugs Today (Barc) 2007 Sep;43(9):627–43.
16. Махонова Л.А. Гистиоцитозы у детей. В рук. по детской онкологии под ред. акад. Л.А. Дурнова. М.: Миклош, 2003. С. 316–24.
17. Пичугина Л.Ю. Клиническое течение и лечение диссеминированных форм лангергансоклеточного гистиоцитоза у детей. Дис. … канд. мед. наук. М., 1999. С. 163.
Review
For citations:
Valiev T.T., Makhonova L.A., Kovrigina A.M., Sholokhova E.N., Tupitsyn N.N., Serebryakova I.N., Mentkevich G.L. Case of congenital Langerhans cells histiocytosis in an infant. Oncohematology. 2011;6(2):19-22. (In Russ.) https://doi.org/10.17650/1818-8346-2011-6-2-19-22